Dyfyniad APA

Zhang, P., Zhang, P., Xie, D., Xie, D., Li, Q., & Li, Q. (2021). Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A.

Dyfyniad Arddull Chicago

Zhang, Peng-Fei, Peng-Fei Zhang, Dan Xie, Dan Xie, Qiu Li, and Qiu Li. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A, 2021.

Dyfyniad MLA

Zhang, Peng-Fei, et al. Adding Enzalutamide to First-Line Treatment for Metastatic Hormone-Sensitive Prostate Cancer: A Cost-Effectiveness Analysis. Frontiers Media S.A, 2021.

Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.